DNA X, Inc. SONM
$2.99
-$0.03-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 7.94% | -2.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 7.94% | -2.83% |
| Cost of Revenue | -- | -- | -- | 33.44% | -- |
| Gross Profit | -- | -- | -- | -57.09% | -- |
| SG&A Expenses | -13.12% | 315.86% | 81.24% | -4.72% | -74.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.12% | 315.86% | 66.90% | 16.07% | -91.82% |
| Operating Income | 13.12% | -315.86% | -89.15% | -67.51% | 77.26% |
| Income Before Tax | 33.44% | -308.74% | -105.31% | -94.70% | 71.73% |
| Income Tax Expenses | -- | -- | -- | -23.08% | -- |
| Earnings from Continuing Operations | 33.44% | -308.74% | -104.16% | -89.21% | 71.89% |
| Earnings from Discontinued Operations | 99.84% | 623.61% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.32% | 1,284.28% | 58.88% | -89.21% | -12.98% |
| EBIT | 13.12% | -315.86% | -89.15% | -67.51% | 77.26% |
| EBITDA | -79.67% | -1,474.59% | -74.21% | -107.68% | 88.02% |
| EPS Basic | 93.48% | 255.00% | 88.54% | 48.25% | 44.34% |
| Normalized Basic EPS | 69.95% | -4.82% | -93.47% | 46.75% | 86.07% |
| EPS Diluted | 93.48% | 255.00% | 88.55% | 48.20% | 44.34% |
| Normalized Diluted EPS | 69.95% | -4.82% | -93.47% | 46.75% | 86.07% |
| Average Basic Shares Outstanding | 155.66% | 289.98% | 175.73% | 265.59% | 103.00% |
| Average Diluted Shares Outstanding | 155.66% | 289.98% | 175.73% | 265.59% | 103.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |